Detalhe da pesquisa
1.
Pharmacokinetics and pharmacodynamics of oleylphosphocholine in a hamster model of visceral leishmaniasis.
J Antimicrob Chemother
; 71(7): 1892-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084920
2.
Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Malar J
; 15(1): 260, 2016 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27150250
3.
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Mycoses
; 58(3): 127-32, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25590577
4.
IRF8 mutations and human dendritic-cell immunodeficiency.
N Engl J Med
; 365(2): 127-38, 2011 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21524210
5.
Challenges faced by multidisplinary new investigators on addressing grand challenges in global health.
Global Health
; 10: 27, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24735677
6.
First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.
Parasitol Res
; 113(1): 157-64, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192865
7.
Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus.
J Exp Med
; 204(3): 511-24, 2007 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-17312006
8.
Pyruvate kinase deficiency in mice protects against malaria.
Nat Genet
; 35(4): 357-62, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14595440
9.
Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice.
Physiol Genomics
; 44(17): 843-52, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22805347
10.
A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.
Hum Mol Genet
; 19(3): 434-44, 2010 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19880857
11.
Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis.
J Antimicrob Chemother
; 67(11): 2707-12, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22782488
12.
Host resistance to malaria: using mouse models to explore the host response.
Mamm Genome
; 22(1-2): 32-42, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21116636
13.
Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Eur J Clin Pharmacol
; 67(3): 267-75, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20949263
14.
Genetic determinants of emotionality and stress response in AcB/BcA recombinant congenic mice and in silico evidence of convergence with cardiovascular candidate genes.
Hum Mol Genet
; 17(3): 331-44, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17913702
15.
Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.
Antimicrob Agents Chemother
; 54(8): 3262-70, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20479197
16.
Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice.
Mamm Genome
; 21(1-2): 28-38, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20012967
17.
Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.
Exp Parasitol
; 125(4): 315-24, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20219464
18.
Genetic control of host-pathogen interactions in mice.
Novartis Found Symp
; 281: 156-65; discussion 165-8, 208-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17534072
19.
The AcB/BcA recombinant congenic strains of mice: strategies for phenotype dissection, mapping and cloning of quantitative trait genes.
Novartis Found Symp
; 281: 141-53; discussion 153-5, 208-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17534071
20.
Mapping cis-acting regulatory variation in recombinant congenic strains.
Physiol Genomics
; 25(2): 294-302, 2006 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16449383